epigenetic target therapeutic (EpiAxis Therapeutics/Peptilogics)

N/A

Report date: 2025/01/26 16:22:30
NME

Base Information

Drug Nameepigenetic target therapeutic (EpiAxis Therapeutics/Peptilogics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEpiaxis Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEpiaxis Therapeutics Pty LtdPeptilogics Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A